Dossier · HNST · Dormant
HNST · The Honest Company, Inc. · Stock research
Last analysed ·
Current thesis
Margin re-rate is consolidating rather than fading: $5.05 on 2026-08-21 is 7.5% under the 2026-08-07 high of $5.46 with RSI down from 83.3 to 72.2, and Morgan Stanley's 2026-08-13 raise to $5.7 restored a target above the market. Nothing discloses a financial figure before the Q3 print (~2026-11-04 est.); September conferences are private investor meetings.
Kill line
A weekly close below $4.60 gives back roughly half the 2026-08-06 earnings-day advance and breaks the margin re-rate leg; secondary break is Q3 adjusted gross margin printing under the mid-40s FY guide at the ~2026-11-04 (est.) report, without the $6.6M tariff-refund credit.
Pick status
Open commitment catalyst in 15dscored if the kill line above fires How this is scored →Latest analysis and events for HNST —
As of 22 August 2026, the latest FrontierPicks analysis for The Honest Company, Inc. (HNST): Margin re-rate is consolidating rather than fading: $5.05 on 2026-08-21 is 7.5% under the 2026-08-07 high of $5.46 with RSI down from 83.3 to 72.2, and Morgan Stanley's 2026-08-13 raise to $5.7 restored a target above the market. Nothing discloses a financial figure before the Q3 print (~2026-11-04 est.); September conferences are private investor meetings.
Kill line: A weekly close below $4.60 gives back roughly half the 2026-08-06 earnings-day advance and breaks the margin re-rate leg; secondary break is Q3 adjusted gross margin printing under the mid-40s FY guide at the ~2026-11-04 (est.) report, without the $6.6M tariff-refund credit.
Next dated event on file: — catalyst in 15d.
Current Thesis
The leg being bought is still the margin re-rate printed on 2026-08-05 — Q2 gross margin 48.4% (+800bps YoY), net income $10.7M against $3.9M a year earlier, and a four-line FY2026 guidance raise — and the question two-and-a-half weeks on is whether the repricing sticks. So far it has consolidated rather than round-tripped: the adjusted close on 2026-08-21 is $5.05, 7.5% under the $5.46 52-week high set 2026-08-07, with RSI(14) at 72.2 against 83.3 at the high and a three-month price change of +48.1%.
Two things have changed since the 2026-08-08 note. Morgan Stanley maintained Equal-Weight and raised its target to $5.7 on 2026-08-13 — the first published target above where the stock trades, after Telsey and B. Riley both moved to $5 on 2026-08-06. And on 2026-08-20 the company announced participation in the Barclays 19th Annual Global Consumer Conference (2026-09-10, Boston) and the Wells Fargo 9th Annual Consumer Conference (2026-09-23, Dana Point) — investor meetings, with no presentation or webcast disclosed, so no new financial disclosure is scheduled between now and the Q3 report.
Bullish and bearish views on The Honest Company, Inc.
The model's bull view on The Honest Company, Inc. (HNST), in brief: The whole FY2026 frame moved on 2026-08-05, not one line of it: revenue to $319–325M, organic growth to 5–7% (prior 4–6%), adjusted gross margin to mid-40s (prior low-40s), adjusted EBITDA to $23–25M (prior $20–23M). The bear view: $6.6M of tariff refunds were recognized as cost reductions inside that 48.4% (Q2 2026 release, 2026-08-05). Both cases follow in full.
Bull Case
- The whole FY2026 frame moved on 2026-08-05, not one line of it: revenue to $319–325M, organic growth to 5–7% (prior 4–6%), adjusted gross margin to mid-40s (prior low-40s), adjusted EBITDA to $23–25M (prior $20–23M).
- Q2 gross margin 48.4%, +800bps YoY, attributed to tariff refunds, mix, and the strategic exits under "Powering Honest Growth" — with organic revenue $80.2M, +6.7%, against reported revenue of $83.3M, down 10.9%.
- A target above the market exists again. Morgan Stanley's 2026-08-13 raise to $5.7 answers one of the open items from the prior note, which flagged that price had run through every published $5 target.
- Cash generation is not theoretical: $37.8M of operating cash flow in H1 2026, $105.9M cash and no debt outstanding, total stockholders' equity $167.0M as of 2026-06-30.
- The company was a buyer before the re-rate: approximately 5.6 million shares repurchased for $18.7M in H1 2026 at a weighted average of $3.35, shrinking the share count ahead of the 2026-08-06 gap.
Bear Case
- $6.6M of tariff refunds were recognized as cost reductions inside that 48.4% (Q2 2026 release, 2026-08-05). The item does not repeat by construction, and the company's own mid-40s full-year adjusted gross margin guide implies compression from the Q2 level.
- Reported revenue is still shrinking — down 10.9% YoY in Q2 — so the growth claim depends entirely on the organic adjustment for exited business.
- Category mix is one-legged. Wire coverage on 2026-08-06 put wipes revenue at +37.3% and diaper revenue at −21.2%. The anchor category is contracting at a double-digit rate.
- Earnings quality is unresolved: Q2 GAAP net income of $10.7M exceeded the $7.8M underlying adjusted EBITDA carried in the same release, which implies a below-the-line contributor doing meaningful work.
- The corporate bid is nearly spent. Roughly $6.3M remained under the repurchase authorization as of 2026-06-30, and what was bought was bought at $3.35 — well under the current tape.
- Ten weeks of no numbers. After the 2026-08-20 conference announcement, the calendar holds nothing that discloses a financial figure until the Q3 print, estimated at ~2026-11-04 (Q3 2025 was reported 2025-11-05).
Setup & Price Structure
The narrative is maturing. The acceleration phase is dated and closed: the 39.2% single-session repricing on 2026-08-06, the high at $5.46 on 2026-08-07, and the last analyst action on 2026-08-13. The only company release since carried no financials (2026-08-20). Price has drifted 7.5% off the high without a new high in two weeks while RSI(14) fell from 83.3 to 72.2 — participation moderating, structure intact. This is not saturated: coverage is four or five sell-side notes and wire summaries, not mainstream saturation. It is no longer accelerating either — the fresh-headline flow stopped on 2026-08-13.
Structure. The reference structure is the 2026-08-06 earnings gap. The $4.60 zone marks roughly half the earnings-day advance; a weekly close under it would mean the market has re-priced the margin story back toward its pre-print frame. Above, the $5.46 high from 2026-08-07 is the level that has capped the move for two weeks.
Crowding and positioning observables (stated as observables, not verdicts):
- RSI(14) 72.2 on 2026-08-21 — still above 70 sixteen sessions after the print.
- Retail-facing momentum screens clustered at the high: a 2026-08-07 Benzinga listicle named HNST at RSI 89.7 alongside JJSF (81.9) and ELF (76.6) as risk-off momentum candidates.
- Most recently reported short interest 4.91M shares, about 4.81% of publicly available shares, down from 4.92M in the prior period (retrieved 2026-08-08). The next FINRA publication (~2026-08-26, est., for the 2026-08-14 settlement date) is the first read on whether shorts covered into the gap or added into it.
- No new Form 4 has surfaced in the filings feed since the print as of 2026-08-21. The 2026 pattern to date has been sell-to-cover on RSU vesting, disclosed as such.
- Buyback capacity of roughly $6.3M as of 2026-06-30 caps how much the issuer itself can absorb.
Catalyst Calendar (next 30 days)
- ~2026-08-26 (est.) — FINRA short-interest publication for the 2026-08-14 settlement date. First positioning read across the earnings gap.
- 2026-09-10 — Barclays 19th Annual Global Consumer Conference, InterContinental Boston. Announced 2026-08-20 as investor meetings; no presentation or webcast disclosed, so any information flow is private to attendees.
- ~2026-09-11 (est.) — FINRA short-interest publication for the 2026-08-31 settlement date.
- 2026-09-23 — Wells Fargo 9th Annual Consumer Conference, Ritz-Carlton Laguna Niguel, Dana Point (just outside the 30-day window; same investor-meeting format).
- ~2026-11-04 (est.) — Q3 2026 results. Outside the window and the only event that puts a number against the mid-40s margin guide without the $6.6M tariff credit.
What Would Change Our Mind
The structure that carries the thesis is the 2026-08-06 gap, and losing half of it would say the margin re-rate was a one-quarter event the market has re-underwritten. Concretely: a weekly close below $4.60 breaks the leg. Below that, the reference points thin out quickly toward the pre-print zone.
On fundamentals, the breaking datapoint is Q3 adjusted gross margin printing under the mid-40s FY guide at the ~2026-11-04 (est.) report, or a trimmed FY revenue range despite the organic guide having been lifted to 5–7%. A discretionary open-market Form 4 sale above $5 that is not tagged as sell-to-cover would be a different signal from the RSU pattern seen at $3.14–$3.34 in May 2026.
What would strengthen the case instead: the ~2026-08-26 short-interest print showing the 4.91M-share base expanding while price holds the $5 area, and Q3 organic growth at or above 7% with adjusted gross margin holding mid-40s once the tariff credit is out of the comparison.
Correlation Notes
- Tariff policy is embedded in the margin line. The $6.6M of refunds recognized in Q2 ties gross margin directly to US tariff administration on imported goods; management indicated on 2026-08-06 that refunds are being reinvested into higher-margin categories, which is a use-of-proceeds decision, not a recurring margin input.
- Small-cap consumer beta. With a sub-$500M market presence and a three-month advance of 48.1%, the name is exposed to Russell 2000 risk appetite independent of execution; a broad small-cap drawdown would test the $4.60 zone without any company news.
- Momentum-cohort grouping. Retail-facing screens placed HNST in the same 2026-08-07 basket as JJSF and ELF on RSI alone. That is a coverage observation rather than a measured correlation, but it describes where marginal attention was coming from at the high.
- Retail channel sensitivity. Growth is concentrated in wipes (+37.3% in Q2 per 2026-08-06 wire coverage) sold through mass and e-commerce retail; shelf and promotional decisions at large retailers move the organic line more than the margin line.
Notes
- Reported and organic revenue diverge sharply because of Powering Honest Growth strategic exits: Q2 2026 reported -10.9%, organic +6.7%. Always check which line a source uses.
- Wire coverage of Q2 adjusted EPS is inconsistent: Benzinga ran $0.09 on 2026-08-05, then a same-day CORRECTION at $0.04. The release's GAAP diluted EPS is $0.09.
- Most 2026 insider Form 4 sales are sell-to-cover on RSU vesting under a Compensation Committee plan, disclosed as such, and are weak evidence about management's view.
- Fiscal year is calendar-aligned and Q3 has landed in early-to-mid November in each of the last two years (2024-11-12, 2025-11-05); the 2026 date was unannounced as of 2026-08-21.
- Share count is moving: approximately 5.6M shares were repurchased in H1 2026, with roughly $6.3M left under the authorization as of 2026-06-30.
Related · shared themes
WEST
Westrock Coffee Company
Conway extract/RTD/flavors platform inflecting capex-to-cash: Q1 (5/07) beat + record adj EBITDA + FCF-positive-H2 guide; the 6/30 debt-maturity extension cleared the refi wall. Stock re-rated to ~$9.50 near the $9.81 52-wk high. Q2 (~2026-08-06) is the next binary — buying a thin sub-$1B micro at range highs into that print is extended.
ALGT
Allegiant Travel Company
Allegiant closed the $1.5B Sun Country acquisition (2026-05-13) to become the largest US leisure airline just as fuel flipped to a tailwind and the whole sell-side re-rated it to $142–$160; the move has more than doubled off the low, and the first partly-combined Q2 print on 2026-08-04 is the binary.
AMC
Amc Entertainment Holdings, Inc.
Box-office recovery flipped from meme-squeeze dormancy to a fundamental earnings inflection: Q2 (2026-07-20) adj EPS $0.14 vs $(0.06) est, revenue $1.597B beat, plus a Wedbush $4 / Benchmark $3 upgrade cluster (2026-07-21). Narrative accelerating, but ~1B shares, ~$4B debt and post-rally ATM-dilution risk cap a chase of the post-print pop.
BH
Biglari Holdings Inc.
Q2 10-Q (filed 2026-08-07) answered the dilution question early: six-month issuance proceeds of $14,920k do not exceed the $15,073k of ATM sales already disclosed through 2026-05-08, so nothing material was sold into the June run to $476.92. Tape still flat — $384.19 (Jul 17) to $388.85 (Aug 21) — with no dated BH catalyst before CBRL's late-September print.
See also · stocks to watch